
Sign up to save your podcasts
Or


Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week's podcast.
By Medscape4.9
862862 ratings
Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week's podcast.

1,875 Listeners

327 Listeners

544 Listeners

707 Listeners

502 Listeners

167 Listeners

15 Listeners

16 Listeners

3,377 Listeners

135 Listeners

1,149 Listeners

62 Listeners

518 Listeners

364 Listeners

61 Listeners

26 Listeners

8 Listeners

265 Listeners

440 Listeners

273 Listeners